Lung Cancer SurgeryEMEA Market Size, Industry Trends, and Statistics Report

Lung Cancer Surgery-EMEA Market Status and Trend Report 2013-2023

Report ID: MIReports 2156 | Number of pages: 149 | Publish Date: Mar 2019 | Category: Medical Devices and Consumables 
Report Summary

Lung Cancer Surgery-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Lung Cancer Surgery industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:

Whole EMEA and Regional Market Size of Lung Cancer Surgery 2013-2017, and development forecast 2018-2023
Main market players of Lung Cancer Surgery in EMEA, with company and product introduction, position in the Lung Cancer Surgery market
Market status and development trend of Lung Cancer Surgery by types and applications
Cost and profit status of Lung Cancer Surgery, and marketing status
Market growth drivers and challenges

The report segments the EMEA Lung Cancer Surgery market as:

EMEA Lung Cancer Surgery Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Europe
Middle East
Africa

EMEA Lung Cancer Surgery Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Surgical Instruments 
Monitoring And Visualization System

EMEA Lung Cancer Surgery Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Lobectomy 
Removal Of Sleeve 
Regional Excision 
Lung Removed All 
Minimally Invasive Surgery

EMEA Lung Cancer Surgery Market: Players Segment Analysis (Company and Product introduction, Lung Cancer Surgery Sales Volume, Revenue, Price and Gross Margin):
Accuray 
Angiodynamics 
Ethicon 
Intuitive Surgical 
Olympus 
Teleflex 
Ackermann Instrumente 
Karl Storz 
Scanlan International 
Trokamed

In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Interested in this report?
Get your sample now!
Download Sample 
Table of Contents
Chapter 1 Overview of Lung Cancer Surgery
    1.1 Definition of Lung Cancer Surgery in This Report
    1.2 Commercial Types of Lung Cancer Surgery
        1.2.1 Surgical Instruments 
        1.2.2 Monitoring And Visualization System
    1.3 Downstream Application of Lung Cancer Surgery
        1.3.1 Lobectomy 
        1.3.2 Removal Of Sleeve 
        1.3.3 Regional Excision 
        1.3.4 Lung Removed All 
        1.3.5 Minimally Invasive Surgery
    1.4 Development History of Lung Cancer Surgery
    1.5 Market Status and Trend of Lung Cancer Surgery 2013-2023
        1.5.1 EMEA Lung Cancer Surgery Market Status and Trend 2013-2023
        1.5.2 Regional Lung Cancer Surgery Market Status and Trend 2013-2023
Chapter 2 EMEA Market Status and Forecast by Regions
    2.1 Market Status of Lung Cancer Surgery in EMEA 2013-2017
    2.2 Consumption Market of Lung Cancer Surgery in EMEA by Regions
        2.2.1 Consumption Volume of Lung Cancer Surgery in EMEA by Regions
        2.2.2 Revenue of Lung Cancer Surgery in EMEA by Regions
    2.3 Market Analysis of Lung Cancer Surgery in EMEA by Regions
        2.3.1 Market Analysis of Lung Cancer Surgery in Europe 2013-2017
        2.3.2 Market Analysis of Lung Cancer Surgery in Middle East 2013-2017
        2.3.3 Market Analysis of Lung Cancer Surgery in Africa 2013-2017
    2.4 Market Development Forecast of Lung Cancer Surgery in EMEA 2018-2023
        2.4.1 Market Development Forecast of Lung Cancer Surgery in EMEA 2018-2023
        2.4.2 Market Development Forecast of Lung Cancer Surgery by Regions 2018-2023
Chapter 3 EMEA Market Status and Forecast by Types
    3.1 Whole EMEA Market Status by Types
        3.1.1 Consumption Volume of Lung Cancer Surgery in EMEA by Types
        3.1.2 Revenue of Lung Cancer Surgery in EMEA by Types
    3.2 EMEA Market Status by Types in Major Countries
        3.2.1 Market Status by Types in Europe
        3.2.2 Market Status by Types in Middle East
        3.2.3 Market Status by Types in Africa
    3.3 Market Forecast of Lung Cancer Surgery in EMEA by Types
Chapter 4 EMEA Market Status and Forecast by Downstream Industry
    4.1 Demand Volume of Lung Cancer Surgery in EMEA by Downstream Industry
    4.2 Demand Volume of Lung Cancer Surgery by Downstream Industry in Major Countries
        4.2.1 Demand Volume of Lung Cancer Surgery by Downstream Industry in Europe
        4.2.2 Demand Volume of Lung Cancer Surgery by Downstream Industry in Middle East
        4.2.3 Demand Volume of Lung Cancer Surgery by Downstream Industry in Africa
    4.3 Market Forecast of Lung Cancer Surgery in EMEA by Downstream Industry
Chapter 5 Market Driving Factor Analysis of Lung Cancer Surgery
    5.1 EMEA Economy Situation and Trend Overview
    5.2 Lung Cancer Surgery Downstream Industry Situation and Trend Overview
Chapter 6 Lung Cancer Surgery Market Competition Status by Major Players in EMEA
    6.1 Sales Volume of Lung Cancer Surgery in EMEA by Major Players
    6.2 Revenue of Lung Cancer Surgery in EMEA by Major Players
    6.3 Basic Information of Lung Cancer Surgery by Major Players
        6.3.1 Headquarters Location and Established Time of Lung Cancer Surgery Major Players
        6.3.2 Employees and Revenue Level of Lung Cancer Surgery Major Players
    6.4 Market Competition News and Trend
        6.4.1 Merger, Consolidation or Acquisition News
        6.4.2 Investment or Disinvestment News
        6.4.3 New Product Development and Launch
Chapter 7 Lung Cancer Surgery Major Manufacturers Introduction and Market Data
    7.1 Accuray 
        7.1.1 Company profile
        7.1.2 Representative Lung Cancer Surgery Product
        7.1.3 Lung Cancer Surgery Sales, Revenue, Price and Gross Margin of Accuray 
    7.2 Angiodynamics 
        7.2.1 Company profile
        7.2.2 Representative Lung Cancer Surgery Product
        7.2.3 Lung Cancer Surgery Sales, Revenue, Price and Gross Margin of Angiodynamics 
    7.3 Ethicon 
        7.3.1 Company profile
        7.3.2 Representative Lung Cancer Surgery Product
        7.3.3 Lung Cancer Surgery Sales, Revenue, Price and Gross Margin of Ethicon 
    7.4 Intuitive Surgical 
        7.4.1 Company profile
        7.4.2 Representative Lung Cancer Surgery Product
        7.4.3 Lung Cancer Surgery Sales, Revenue, Price and Gross Margin of Intuitive Surgical 
    7.5 Olympus 
        7.5.1 Company profile
        7.5.2 Representative Lung Cancer Surgery Product
        7.5.3 Lung Cancer Surgery Sales, Revenue, Price and Gross Margin of Olympus 
    7.6 Teleflex 
        7.6.1 Company profile
        7.6.2 Representative Lung Cancer Surgery Product
        7.6.3 Lung Cancer Surgery Sales, Revenue, Price and Gross Margin of Teleflex 
    7.7 Ackermann Instrumente 
        7.7.1 Company profile
        7.7.2 Representative Lung Cancer Surgery Product
        7.7.3 Lung Cancer Surgery Sales, Revenue, Price and Gross Margin of Ackermann Instrumente 
    7.8 Karl Storz 
        7.8.1 Company profile
        7.8.2 Representative Lung Cancer Surgery Product
        7.8.3 Lung Cancer Surgery Sales, Revenue, Price and Gross Margin of Karl Storz 
    7.9 Scanlan International 
        7.9.1 Company profile
        7.9.2 Representative Lung Cancer Surgery Product
        7.9.3 Lung Cancer Surgery Sales, Revenue, Price and Gross Margin of Scanlan International 
    7.10 Trokamed
        7.10.1 Company profile
        7.10.2 Representative Lung Cancer Surgery Product
        7.10.3 Lung Cancer Surgery Sales, Revenue, Price and Gross Margin of Trokamed
Chapter 8 Upstream and Downstream Market Analysis of Lung Cancer Surgery
    8.1 Industry Chain of Lung Cancer Surgery
    8.2 Upstream Market and Representative Companies Analysis
    8.3 Downstream Market and Representative Companies Analysis
Chapter 9 Cost and Gross Margin Analysis of Lung Cancer Surgery
    9.1 Cost Structure Analysis of Lung Cancer Surgery
    9.2 Raw Materials Cost Analysis of Lung Cancer Surgery
    9.3 Labor Cost Analysis of Lung Cancer Surgery
    9.4 Manufacturing Expenses Analysis of Lung Cancer Surgery
Chapter 10 Marketing Status Analysis of Lung Cancer Surgery
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List
Chapter 11 Report Conclusion
Chapter 12 Research Methodology and Reference
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Reference


List of Tables

    Table Advantage and Disadvantage of Surgical Instruments 
    Table Advantage and Disadvantage of Monitoring And Visualization System
    Table Consumption Volume of Lung Cancer Surgery in EMEA by Regions 2013-2017
    Table Revenue of Lung Cancer Surgery in EMEA by Regions 2013-2017
    Table Consumption Volume of Lung Cancer Surgery in EMEA by Regions 2018-2023
    Table Revenue of Lung Cancer Surgery in EMEA by Regions 2018-2023
    Table Consumption Volume of Lung Cancer Surgery in EMEA by Types 2013-2017
    Table Revenue of Lung Cancer Surgery in EMEA by Types 2013-2017
    Table Consumption Volume of Lung Cancer Surgery by Types in Europe 2013-2017
    Table Consumption Volume of Lung Cancer Surgery by Types in Middle East 2013-2017
    Table Consumption Volume of Lung Cancer Surgery by Types in Africa 2013-2017
    Table Consumption Volume Forecast of Lung Cancer Surgery in EMEA by Types 2018-2023
    Table Revenue Forecast of Lung Cancer Surgery in EMEA by Types 2018-2023
    Table Demand Volume of Lung Cancer Surgery in EMEA by Downstream Industry 2013-2017
    Table Demand Volume of Lung Cancer Surgery by Downstream Industry in Europe 2013-2017
    Table Demand Volume of Lung Cancer Surgery by Downstream Industry in Middle East 2013-2017
    Table Demand Volume of Lung Cancer Surgery by Downstream Industry in Africa 2013-2017
    Table Demand Volume Forecast of Lung Cancer Surgery in EMEA by Downstream Industry 2018-2023
    Table Sales Volume of Lung Cancer Surgery in EMEA by Major Players 2013-2017
    Table Revenue of Lung Cancer Surgery in EMEA by Major Players 2013-2017
    Table Headquarters Location and Established Time of Lung Cancer Surgery Major Players
    Table Employees and Revenue Level of Lung Cancer Surgery Major Players
    Table Representative Lung Cancer Surgery Product One of Accuray 
    Table Representative Lung Cancer Surgery Product Two of Accuray 
    Table Lung Cancer Surgery Sales, Revenue, Price and Gross Margin of Accuray  2013-2017
    Table Representative Lung Cancer Surgery Product One of Angiodynamics 
    Table Representative Lung Cancer Surgery Product Two of Angiodynamics 
    Table Lung Cancer Surgery Sales, Revenue, Price and Gross Margin of Angiodynamics  2013-2017
    Table Representative Lung Cancer Surgery Product One of Ethicon 
    Table Representative Lung Cancer Surgery Product Two of Ethicon 
    Table Lung Cancer Surgery Sales, Revenue, Price and Gross Margin of Ethicon  2013-2017
    Table Representative Lung Cancer Surgery Product One of Intuitive Surgical 
    Table Representative Lung Cancer Surgery Product Two of Intuitive Surgical 
    Table Lung Cancer Surgery Sales, Revenue, Price and Gross Margin of Intuitive Surgical  2013-2017
    Table Representative Lung Cancer Surgery Product One of Olympus 
    Table Representative Lung Cancer Surgery Product Two of Olympus 
    Table Lung Cancer Surgery Sales, Revenue, Price and Gross Margin of Olympus  2013-2017
    Table Representative Lung Cancer Surgery Product One of Teleflex 
    Table Representative Lung Cancer Surgery Product Two of Teleflex 
    Table Lung Cancer Surgery Sales, Revenue, Price and Gross Margin of Teleflex  2013-2017
    Table Representative Lung Cancer Surgery Product One of Ackermann Instrumente 
    Table Representative Lung Cancer Surgery Product Two of Ackermann Instrumente 
    Table Lung Cancer Surgery Sales, Revenue, Price and Gross Margin of Ackermann Instrumente  2013-2017
    Table Representative Lung Cancer Surgery Product One of Karl Storz 
    Table Representative Lung Cancer Surgery Product Two of Karl Storz 
    Table Lung Cancer Surgery Sales, Revenue, Price and Gross Margin of Karl Storz  2013-2017
    Table Representative Lung Cancer Surgery Product One of Scanlan International 
    Table Representative Lung Cancer Surgery Product Two of Scanlan International 
    Table Lung Cancer Surgery Sales, Revenue, Price and Gross Margin of Scanlan International  2013-2017
    Table Representative Lung Cancer Surgery Product One of Trokamed
    Table Representative Lung Cancer Surgery Product Two of Trokamed
    Table Lung Cancer Surgery Sales, Revenue, Price and Gross Margin of Trokamed 2013-2017